Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer

Lin Wang,Xiang-Bo Ji,Li-Hong Wang,Jian-Ge Qiu,Feng-Mei Zhou,Wen-Jing Liu,Di-di Wan,Marie Chai-mi Lin,Ling-Zhi Liu,Jian-Ying Zhang,Bing-Hua Jiang

DOI: https://doi.org/10.3389/fcell.2020.00840

IF: 5.5

2020-09-08

Frontiers in Cell and Developmental Biology

Abstract:<span><b>Background:</b> MicroRNA-497 (miR-497) has been implicated in several cancers. Increasing studies demonstrate the role of AKT2 in cancers as an oncogene which is closely associated with tumor aggressiveness by enhancing cancer cell survival, migration and invasion However, miR-497/AKT2 axis in non-small cell lung cancer (NSCLC) remains unclear.<b>Methods:</b> Quantitative real-time PCR (qRT-PCR) was used to quantify the expression of miR-497 and its target gene. The function of miR-497 in lung cancer was investigated through <i>in vitro</i> and <i>in vivo</i> assays (cell proliferation assay, cell migration assay, colony formation assay, flow cytometry assay, immunoblotting and tumorigenesis assay). Luciferase reporter assay was conducted to confirm the target gene of miR-497.<b>Results:</b> In this study, we found that miR-497 was significantly downregulated in tumor tissues and blood samples of lung cancer patients. To understand the potential mechanism of miR-497 in inhibiting tumor growth, we showed that miR-497 blocked the activation of AKT2 and regulated cell proliferation, cell migration, colony formation and increases chemosensitivity of H1299 cells to cisplatin by inhibiting AKT2. MiR-497 also inhibited tumor growth and suppressed expression of AKT2 at the protein and mRNA levels in mouse xenograft tumors.<b>Conclusion:</b> Taken together, our findings indicated that miR-497 suppresses the tumor growth by targeting AKT2, and the miR-497/AKT2 axis is a potential therapeutic target for NSCLC intervention.</span>

cell biology,developmental biology

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the following aspects:

1. **Expression of microRNA - 497 (miR - 497) in non - small - cell lung cancer (NSCLC) and its relationship with disease progression**: The study found that the expression of miR - 497 was significantly reduced in lung cancer tissues and patient blood samples, and its expression level was related to tumor stage and lymph node metastasis status. This indicates that miR - 497 may be a potential biomarker for NSCLC.

2. **Targeting effect of miR - 497 on AKT2 and its mechanism**: Through bioinformatics analysis and experimental verification, the study confirmed that AKT2 is a direct target gene of miR - 497. miR - 497 inhibits its expression by binding to the 3' - untranslated region (3' - UTR) of AKT2, thereby affecting downstream signaling pathways.

3. **Effect of miR - 497 on the functions of lung cancer cells**: Over - expression of miR - 497 can inhibit the proliferation, migration and clonogenic ability of lung cancer cells, and increase the sensitivity of cells to cisplatin (CDDP). These results indicate that miR - 497 has a tumor - suppressing effect in lung cancer.

4. **Inhibitory effect of miR - 497 on tumor growth in vivo**: Through the nude mouse xenograft tumor model, the study further confirmed the anti - tumor effect of miR - 497 in vivo, which was manifested as a significant reduction in tumor volume and weight.

In summary, this paper aims to explore the biological functions of miR - 497 in non - small - cell lung cancer, especially its mechanism of inhibiting tumor growth and enhancing chemosensitivity by targeting AKT2. These findings provide new potential targets for the diagnosis, prevention and treatment of NSCLC.